In-Person CME Webcast
1.00 CME/CE Credit
Childhood Vaccines & Immunizations: Current Technologies and Contemporary Challenges
Pandemics and tropical infectious diseases are on the rise due to a confluence of climate change and urbanization, including areas of Texas and the Gulf Coast. Our Texas Children’s Hospital Center for Vaccine Development is developing new vaccines for the neglected and tropical diseases arising from these 21st Century forces including a new hookworm anemia showing high levels of protective immunity in a challenge infection model (CHIM) and a low-cost COVID-19 vaccine technology administered to more than 100 million people in low- and middle-income countries. But new vaccines alone won’t address the global declines in vaccine uptake arising from an antivaccine ecosystem that first accelerated in the U.S. more than 25 years ago and now globalizing. As both a vaccine scientist and parent of adult daughter with autism and intellectual disabilities, Dr. Hotez has had a front row seat to the antivaccine movement and its evolution. An estimated 200,000 Americans died needlessly because they refused COVID immunizations in 2021-22 – they were victims of politically motivated antivaccine activism, now spilling over into childhood immunizations. Potential solutions are discussed.
CME/CE Information
1.00 AMA PRA Category 1 Credits™ or 1.00 AANP, including 1.00 AANP Pharm
Release Date: 5/8/2026
Expiration Date: 6/21/2026
Learning Objectives
- Report on the successes of the Gavi Vaccine Alliance in reducing the deaths from childhood illnesses
- Summarize efforts at the Texas Children’s Hospital Center for Vaccine
- Development to develop new vaccines for neglected diseases in low- and middle-income countries
- Summarize the origins of rising antivaccine sentiments and its recent shifts
- Create awareness on approaches to countering antivaccine activities
Faculty
Peter J. Hotez, MD, PhD, DSc (hon), FASTMH, FAAP
Dean, National School of Tropical Medicine, Professor, Departments of Pediatrics, Molecular Virology & Microbiology, Baylor College of Medicine, Houston, Texas
Health Policy Scholar, Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, Texas
Endowed Chair of Tropical Pediatrics, Co-Director, Texas Children’s Hospital Center for Vaccine Development, Texas Children's Hospital, Houston, Texas
Senior Fellow in Disease and Humanity, James A. Baker III Institute of Public Policy, Rice University
Senior Fellow, Scowcroft Institute of International Affairs, Texas A&M University
Learn MoreDisclosures
The following relevant financial relationships have been disclosed by those in a position to influence the content of this activity. All have been mitigated by Pri-Med Institute:
Richard Hamill, MD (Planner): Researcher for Pfizer
All others in control of content for this activity have disclosed no relevant financial relationships.
CME/CE Information
AMA PRA Category 1 Credits™
Accreditation Statement
Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement
Pri-Med Institute designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AANP
Accreditation Statement
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of Pri-Med Institute and Baylor College of Medicine.Pri-Med Institute is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider Number 040308.
Designation Statement
This activity is approved for 1.00 contact hour, which includes 1.00 hour of pharmacology.
Fine Print
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.
The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.
Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.
Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.
Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP.
Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME/CE activities to disclose personal financial relationships with commercial interests or ineligible companies prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to mitigate real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. All relevant financial relationships have been mitigated Financial disclosures for everyone in control of educational content are provided before the start of each CME/CE activity.
Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.
Questions?
If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.